Cardiac nuclear high mobility group box 1 prevents the development of cardiac hypertrophy and heart failure

Cardiovascular Research

Volumn 99, Issue 4, 2013, Pages 657-664

  Funayama, Akira ^a   Shishido, Tetsuro ^a   Netsu, Shunsuke ^a   Narumi, Taro ^a   Kadowaki, Shinpei ^a   Takahashi, Hiroki ^a   Miyamoto, Takuya ^a   Watanabe, Tetsu ^a   Woo, Chang Hoon ^b   Abe, Jun Ichi ^c   Kuwahara, Koichiro ^d   Nakao, Kazuwa ^d   Takeishi, Yasuchika ^e   Kubota, Isao ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b Yeungnam University College of Medicine   (South Korea)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Acetylation; Heart failure; HMGB1; Pressure overload; Translocation

Indexed keywords

ANGIOTENSIN II; ENDOTHELIN 1; HIGH MOBILITY GROUP B1 PROTEIN;

ACETYLATION; ADULT; AGED; ANIMAL CELL; AORTA CONSTRICTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DNA DAMAGE; FEMALE; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HUMAN; MALE; NEWBORN; NONHUMAN; PRESSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SURVIVAL RATE; THORACIC AORTA;

ACETYLATION; HEART FAILURE; HMGB1; PRESSURE OVERLOAD; TRANSLOCATION;

ACETYLATION; ANIMALS; ATRIAL NATRIURETIC FACTOR; CARDIOMEGALY; CELL NUCLEUS; ENDOTHELIN-1; HEART FAILURE; HMGB1 PROTEIN; HUMANS; MICE; MYOCARDIUM; PROTEIN TRANSPORT; RATS;

EID: 84883252918     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvt128     Document Type: Article

References (37)

1. Jessup M, Brozena S. Heart failure. N Engl J Med 2003;348:2007-2018.
2. McMurray JJ, Pfeffer MA. Heart failure. Lancet 2005;365:1877-1889.
3. Roger VL, Weston SA, Redfield MM, Hellermann-Homan JP, Killian J, Yawn BP et al. Trends in heart failure incidence and survival in a community-based population. JAMA 2004;292:344-350.
4. Rame JE, Ramilo M, Spencer N, Blewett C, Mehta SK, Dries DL et al. Development of a depressed left ventricular ejection fraction in patients with left ventricular hypertrophy and a normal ejection fraction. Am J Cardiol 2004;93:234-237.
5. Nightingale K, Dimitrov S, Reeves R,Wolffe AP. Evidence for a shared structural role for HMG1 and linker histones B4 and H1 in organizing chromatin. EMBO J 1996;15: 548-561.
6. Lange SS, Mitchell DL, Vasquez KM. High mobility group protein B1 enhances DNA repair and chromatin modification after DNA damage. Proc Natl Acad Sci USA 2008; 105:10320-10325.
7. Calogero S, Grassi F, Aguzzi A, Voigtlander T, Ferrier P, Ferrari S et al. The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice. Nat Genet 1999;22:276-280.
8. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002;418:191-195.
9. Yang H, Hreggvidsdottir HS, Palmblad K,Wang H, Ochani M, Li J et al. Acritical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc Natl Acad Sci USA 2010;107:11942-11947.
10. Lotze MT, Tracey KJ. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 2005;5:331-342.
11. Germani A, Limana F, Capogrossi MC. Pivotal advances: high-mobility group box 1 protein-A cytokine with a role in cardiac repair. J Leukoc Biol 2007;81:41-45.
12. Kitahara T, Takeishi Y, Harada M, Niizeki T, Suzuki S, Sasaki T et al. High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice. Cardiovasc Res 2008;80:40-46.
13. Andrassy M, Volz HC, Riedle N, Gitsioudis G, Seidel C, LaohachewinDet al.HMGB1 as a predictor of infarct transmurality and functional recovery in patients with myocardial infarction. J Intern Med 2011;270:245-253.
14. Suzuki S, Shishido T, Ishino M, Katoh S, Sasaki T, Nishiyama S et al. 8-Hydroxy-2Q-deoxyguanosine is a prognostic mediator for cardiac event. Eur J Clin Invest 2011;41:759-766.
15. Prasad R, Liu Y, Deterding LJ, Poltoratsky VP, Kedar PS, Horton JK et al. HMGB1 is a cofactor in mammalian base excision repair. Mol Cell 2007;27:829-841.
16. Evankovich J, ChoSW, Zhang R, Cardinal J, Dhupar R, Zhang L et al. High mobility group box 1 release from hepatocytes during ischemia and reperfusion injury is mediated by decreased histone deacetylase activity. J Biol Chem 2010;285:39888-39897.
17. Bonaldi T, Talamo F, Scaffidi P, Ferrera D, Porto A, Bachi A et al. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J 2003;22: 5551-5560.
18. Tang D, Kang R, Livesey KM, Kroemer G, Billiar TR, Van Houten B et al. High-mobility group box 1 is essential for mitochondrial quality control. Cell Metab 2011;13:701-711.
19. El Gazzar M, Yoza BK, Chen X, Garcia BA, Young NL, McCall CE. Chromatin-specific remodeling by HMGB1 and linker histone H1 silences proinflammatory genes during endotoxin tolerance. Mol Cell Biol 2009;29:1959-1971.
20. Enokido Y, Yoshitake A, Ito H, Okazawa H. Age-dependent change ofHMGB1andDNA double-strand break accumulation in mouse brain. Biochem Biophys Res Commun 2008; 376:128-133.
21. QiML, TagawaK, EnokidoY, YoshimuraN,Wada Y,WataseK et al. Proteome analysis of soluble nuclear proteins reveals that HMGB1/2 suppress genotoxic stress in polyglutamine diseases. Nat Cell Biol 2007;9:402-414.
22. Kuwahara K, Saito Y, Ogawa E, Takahashi N, Nakagawa Y, Naruse Y et al. The neuronrestrictive silencer element-neuron-restrictive silencer factor system regulates basal and endothelin 1-inducible atrial natriuretic peptide gene expression in ventricular myocytes. Mol Cell Biol 2001;21:2085-2097.
23. Kuwahara K, Saito Y, Takano M, Arai Y, Yasuno S, Nakagawa Y et al. NRSF regulates the fetal cardiac gene program and maintains normal cardiac structure and function. EMBO J 2003;22:6310-6321.
24. Shishido T,Woo CH, Ding B, McClain C, Molina CA, Yan C et al. Effects of MEK5/ERK5 association on small ubiquitin-related modification of ERK5: implications for diabetic ventricular dysfunction after myocardial infarction. Circ Res 2008;102:1416-1425.
25. Le NT, Takei Y, Shishido T, Woo CH, Chang E, Heo KS et al. p90RSK targets the ERK5-CHIP ubiquitin E3 ligase activity in diabetic hearts and promotes cardiac apoptosis and dysfunction. Circ Res 2012;110:536-550.
26. Woo CH, MassettMP, Shishido T, Itoh S, Ding B, McClainCet al. ERK5 activation inhibits inflammatory responses via peroxisome proliferator-activated receptor delta (PPARdelta) stimulation. J Biol Chem 2006;281:32164-32174.
27. Woo CH, Le NT, Shishido T, Chang E, Lee H, Heo KS et al. Novel role of C terminus of Hsc70-interacting protein (CHIP) ubiquitin ligase oninhibiting cardiac apoptosis and dysfunction via regulating ERK5-mediated degradation of inducible cAMP early repressor. FASEB J 2010;24:4917-4928.
28. Pallier C, Scaffidi P, Chopineau-Proust S, Agresti A, Nordmann P, Bianchi ME et al. Association of chromatin proteins high mobility group box (HMGB) 1 and HMGB2 with mitotic chromosomes. Mol Biol Cell 2003;14:3414-3426.
29. Murai K, Naruse Y, Shaul Y, Agata Y, Mori N. Direct interaction of NRSF with TBP: chromatin reorganization and core promoter repression for neuron-specific gene transcription. Nucleic Acids Res 2004;32:3180-3189.
30. Andrassy M, Volz HC, Igwe JC, Funke B, Eichberger SN, KayaZet al. High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation 2008;117:3216-3226.
31. Limana F, Germani A, Zacheo A, Kajstura J, Di Carlo A, Borsellino G et al. Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation. Circ Res 2005; 97:e73-e83.
32. El Gazzar M.HMGB1modulates inflammatory responses in LPS-activated macrophages. Inflamm Res 2007;56:162-167.
33. Treutiger CJ, Mullins GE, Johansson AS, Rouhiainen A, Rauvala HM, Erlandsson-HarrisH et al. High mobility group 1 B-box mediates activation of human endothelium. J Intern Med 2003;254:375-385.
34. Assenberg R,Webb M, Connolly E, Stott K,Watson M, Hobbs J et al. A critical role in structure-specific DNA binding for the acetylatable lysine residues in HMGB1. Biochem J 2008;411:553-561.
35. Pasheva E, Sarov M, Bidjekov K, Ugrinova I, Sarg B, Lindner H et al. In vitro acetylation of HMGB-1 and-2 proteins by CBP: the role of the acidic tail. Biochemistry 2004; 43:2935-2940.
36. Ugrinova I, Pashev IG, Pasheva EA. Nucleosome binding properties and Co-remodeling activities of native and in vivo acetylated HMGB-1 and HMGB-2 proteins. Biochemistry 2009;48:6502-6507.
37. Siggens L, Figg N, Bennett M, Foo R. Nutrient deprivation regulatesDNA damage repair in cardiomyocytes via loss of the base-excision repair enzyme OGG1. FASEB J 2012; 26:2117-2124.